UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Severance Hospital develops AI-platform detecting gastric cancer with high accuracy
by Lee Han-soo
2019-10-08 16:06
Korea, Peru compare notes on telemedicine
by Lee Han-soo
2019-10-08 15:20
Propofol abuse, addiction increasing at alarming rate
by Lee Han-soo
2019-10-07 17:56
Yuyang DNU, NSCI to develop treatment for dry macular degeneration
by Lee Han-soo
2019-10-07 16:54
Regulator remains unclear on who got Allergan's breast implant
by Lee Han-soo
2019-10-07 14:58
라인
Sanofi confirms prolonged PFS in patients with advanced gastric cancer
by Lee Han-soo
2019-10-07 14:39
SK Plasma launches human immunoglobulin in Brazil
by Lee Han-soo
2019-10-07 11:23
Qurient sets up joint firm with Nobel chemistry prize winner
by Lee Han-soo
2019-10-04 17:45
Lilly's Verzenio extends life for women with advanced breast cancer
by Lee Han-soo
2019-10-04 16:15
Regulator under fire for neglecting reported side effects of Invossa
by Lee Han-soo
2019-10-04 14:59
라인
Severance confirms efficacy, safety of Yuhan's lung cancer drug Lazertinib
by Lee Han-soo
2019-10-04 14:39
Foreign patients visiting Korea rise by 17.8% in 2018
by Lee Han-soo
2019-10-02 17:50
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
by Lee Han-soo
2019-10-02 16:10
Daewoong's EU partner wins sales approval for BTX
by Lee Han-soo
2019-10-02 14:51
Anorexia craze among Korean girls raises concerns
by Lee Han-soo
2019-10-02 11:34
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
by Lee Han-soo
2019-10-01 16:43
Cost of smartphone-related illness tops ₩400 billion in 2018
by Lee Han-soo
2019-10-01 15:47
Researchers say global anti-thrombotic drug guideline too much for Koreans
by Lee Han-soo
2019-10-01 14:08
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
by Lee Han-soo
2019-10-01 11:21
Drug regulator under fire for going too far, too late
by Lee Han-soo
2019-09-27 17:48
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top